What it is

Kisspeptin is a family of peptides derived from the KISS1 gene product. In humans and in the literature, you’ll see different lengths discussed (for example kisspeptin‑54 and kisspeptin‑10).

Why people care

Kisspeptin is one of the strongest known upstream signals that can stimulate the reproductive hormone axis. At a high level, it acts above gonadotropin-releasing hormone (GnRH), which is the hypothalamic signal that drives pituitary release of LH and FSH.

That biology has made kisspeptin interesting in:

reproductive physiology research
select clinical fertility contexts (for example, IVF-related work)
“HRT-adjacent” market chatter (often ahead of evidence)

Evidence landscape

Kisspeptin has a substantial basic science and human physiology literature. Clinical exploration exists in reproductive medicine, but broad off-label use claims should be treated cautiously.

Latest updates

2026-03-25: Added as a directory entry because kisspeptin is increasingly discussed as a potential “HRT-adjacent” peptide and has real reproductive physiology and clinical fertility literature.

Safety reality

Kisspeptin is a potent upstream signal. Safety depends heavily on indication, formulation, dosing, monitoring, and patient context. We do not provide dosing advice.

References

“Kisspeptin and neurokinin B: roles in reproductive health.” Physiological Reviews (2025). https://pubmed.ncbi.nlm.nih.gov/39813600/
“Use of kisspeptin to trigger oocyte maturation during in vitro fertilisation (IVF) treatment.” Frontiers in Endocrinology (2022). https://pubmed.ncbi.nlm.nih.gov/36147569/